Oncology
Clinical Study
Earlier Onset and Poor Prognosis of Lung Cancer in Imprisoned PatientsCarbonnaux M.a, d · Fossard G.a, d · Amzallag E.b · Piegay C.c · Perot E.a, d · Chossegros P.b · Souquet P.J.a, d · Couraud S.a, daDepartment of Pulmonary Medicine, bInterregional Secure Hospital Unit, and cDepartment of Medical Information, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre Bénite, and dFaculty of Medicine Lyon Sud, Lyon 1 University, Oullins, France
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: May 08, 2013
Accepted: October 23, 2013
Published online: December 10, 2013
Issue release date: December 2013
Number of Print Pages: 8
Number of Figures: 1
Number of Tables: 3
ISSN: 0030-2414 (Print)
eISSN: 1423-0232 (Online)
For additional information: https://www.karger.com/OCL
Abstract
Introduction: Prison inmates are known to be more exposed to various lung cancer risk factors, and some studies have shown that lung cancer is the most common cancer in prisoners. However, no study has particularly focused on lung cancer features in this population. Method: Charts of patients with lung cancer hospitalized in one of the French secured hospital units between 1997 and 2012 were reviewed. Data from this cohort were then compared to those of two large observational studies conducted in 2000 and 2010 (KBP studies). Results: Thirty-two cases were included. All were men. The mean age was 52.2 ± 11.5 years, which was significantly lower than in the KBP-2000 (64.4 years) and KBP-2010 (65.5 years; both p < 0.0001) studies. The percentage of current smokers was much higher in prisoners (87.1 vs. 52.2 and 49.2%, respectively; both p < 0.001). Ninety percent of prisoners presented with at least one comorbidity. Lung cancer clinical presentation did not differ between prisoners and the reference populations. The median overall survival was 5.8 months (range 0-15.1) for all stages and 4.7 months (range 2.8-6.6) for stage IIIB/IV. Conclusion: Although our study suffers from limitations, prisoners seem to develop lung cancer at a younger age and their prognosis is poor.
© 2013 S. Karger AG, Basel
Related Articles:
References
-
Francim/Hospices civils de Lyon/INCa/Inserm/INVs 2011: Estimated incidence and mortality of 5 major cancers in France in 2011. Fr Natl Cancer Inst Off Website. 2011. http://lesdonnees.e-cancer.fr/les-indicateurs/1-types-cancer/12-cancer-poumon/36-epidemiologie-cancer-poumon-france-metropolitaine-incidence/68-incidence-mortalite-estimees-cancers-5-principales-localisations-france-2011-tous-sexe.html (accessed March 12, 2012).
- Blanchon F, Grivaux M, Collon T, Zureik M, Barbieux H, Bénichou-Flurin M, et al: Epidemiologic of primary bronchial carcinoma management in the general French hospital centers. Rev Mal Respir 2002;19:727-734.
- Grivaux M, Zureik M, Marsal L, Asselain B, Peureux M, Chavaillon JM, et al: Five-year survival for lung cancer patients managed in general hospitals. Rev Mal Respir 2011;28:e31-e38.
- Grivaux M, Locher C, Bombaron P, Collon T, Coëtmeur D, Dayen C, et al: Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31 December 2010. Rev Pneumol Clin 2010;66:375-382.
- Locher C, Debieuvre D, Coëtmeur D, Goupil F, Molinier O, Collon T, et al: Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies. Lung Cancer 2013;81:32-38.
- Pesch B, Kendzia B, Gustavsson P, Jöckel KH, Johnen G, Pohlabeln H, et al: Cigarette smoking and lung cancer - relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer 2012;131:1210-1219.
- Liang HY, Li XL, Yu XS, Guan P, Yin ZH, He QC, et al: Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer 2009;125:2936-2944.
- Sidorchuk A, Agardh EE, Aremu O, Hallqvist J, Allebeck P, Moradi T: Socioeconomic differences in lung cancer incidence: a systematic review and meta-analysis. Cancer Causes Control 2009;20:459-471.
- Couraud S, Zalcman G, Milleron B, Morin F, Souquet PJ: Lung cancer in never smokers - a review. Eur J Cancer 2012;48:1299-1311.
- Sewell RA, Cohn AJ, Chawarski MC: Doubts about the role of cannabis in causing lung cancer. Eur Respir J 2008;32:815-816.
- Berthiller J, Straif K, Boniol M, Voirin N, Benhaïm-Luzon V, Ayoub WB, et al: Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol 2008;3:1398-1403.
- Aldington S, Harwood M, Cox B, Weatherall M, Beckert L, Hansell A, et al: Cannabis use and risk of lung cancer: a case-control study. Eur Respir J 2008;31:280-286.
- Tardon A, Lee WJ, Delgado-Rodriguez M, Dosemeci M, Albanes D, Hoover R, et al: Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control 2005;16:389-397.
- Fazel S, Baillargeon J: The health of prisoners. Lancet 2011;377:956-965.
-
Direction de l'Administration Pénitentiaire, Bureau des études, de la prospective et des methods: Statistique mensuelle de la population écrouée et détenue en France. Situation au 1er Juin 2013. Paris, Ministère de la Justice, p 17. http://www.justice.gouv.fr/art_pix/mensuelle_inTERnet_juin_2013.pdf.
-
Direction de la Recherche des Etudes de l'Evaluation et des Statistiques, Mounet MC: La santé des personnes entrées en prisons en 2003 (report 386). Paris, Ministère de l'emploi, du travail et de la cohésion sociale, Ministère des solidarités, de la santé et de la famille. 2005. http://www.drees.sante.gouv.fr/la-sante-des-personnes-entrees-en-prison-en-2003,4513.html.
- Lukasiewicz M, Falissard B, Michel L, Neveu X, Reynaud M, Gasquet I: Prevalence and factors associated with alcohol and drug-related disorders in prison: a French national study. Subst Abuse Treat Prev Policy 2007;2:1.
- Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F: Tuberculosis incidence in prisons: a systematic review. PLoS Med 2010;7:e1000381.
- Mathew P, Elting L, Cooksley C, Owen S, Lin J: Cancer in an incarcerated population. Cancer 2005;104:2197-2204.
- Davies EA, Sehgal A, Linklater KM, Heaps K, Moren C, Walford C, et al: Cancer in the London prison population, 1986-2005. J Public Health (Oxf) 2010;32:526-531.
- Rosen DL, Wohl DA, Schoenbach VJ: All-cause and cause-specific mortality among black and white North Carolina state prisoners, 1995-2005. Ann Epidemiol 2011;21:719-726.
-
Arrêté du 24 août 2000 relatif à la création des unités hospitalières sécurisées interrégionales destinées à l'accueil des personnes incarcérées. J Off République Française, August 31, 2000.
-
Ministère de la Justice: Prison et réinsertion - La vie en détention - La santé. Fr Site Off Ministère Justice. 2012. http://www.justice.gouv.fr/prison-et-reinsertion-10036/la-vie-en-detention-10039/la-sante-10026.html (accessed March 12, 2012).
- Sannier O, Gignon M, Defouilloy C, Hermant A, Manaouil C, Jardé O: Obstructive lung diseases in a French prison: results of systematic screening. Rev Pneumol Clin 2009;65:1-8.
-
Couraud S, Fournel P, Moro-Sibilot D, Pérol M, Souquet PJ: Professional practice and accessibility to equipment in thoracic oncology. Results of a survey in Rhônes-Alpes region (France). Bull Cancer (Paris) 2011, E-pub ahead of print.
- Binswanger IA, Merrill JO, Krueger PM, White MC, Booth RE, Elmore JG: Gender differences in chronic medical, psychiatric, and substance-dependence disorders among jail inmates. Am J Public Health 2010;100:476-482.
- Parsons A, Daley A, Begh R, Aveyard P: Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010;340:b5569.
- Giroux Leprieur E, Labrune S, Giraud V, Gendry T, Cobarzan D, Chinet T: Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer. Clin Lung Cancer 2012;13:363-368.
- Olive F, Gomez F, Schott AM, Remontet L, Bossard N, Mitton N, et al: Critical analysis of French DRG based information system (PMSI) databases for the epidemiology of cancer: a longitudinal approach becomes possible. Rev Epidemiol Sante Publique 2011;59:53-58.
- Moro D, Nagy-Mignotte H, Bolla M, Colonna M, Brichon PY, Brambilla C, et al: Evaluation of survival and prognostic factors of 2,000 broncho-pulmonary cancers registered during 10 years in a multidisciplinary oncology department. Bull Cancer (Paris) 1997;84:155-161.
Article / Publication Details
Received: May 08, 2013
Accepted: October 23, 2013
Published online: December 10, 2013
Issue release date: December 2013
Number of Print Pages: 8
Number of Figures: 1
Number of Tables: 3
ISSN: 0030-2414 (Print)
eISSN: 1423-0232 (Online)
For additional information: https://www.karger.com/OCL
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission